Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Some breast cancer chemotherapy can cause permanent hair loss.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Lower LDL-c levels predict higher COVID-19 mortality.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A hospital outbreak of catheter infections in calves was caused by a bacteria from a beef herd, leading to longer hospital stays, more drug use, and calf deaths.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.